<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1397</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>33</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Role of platelet-derived microparticles in transfer of the chemokine receptor CXCR4 to CXCR4-negative cells</title>
	<subject_fa></subject_fa>
	<subject>Legal Medicine</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Membrane-derived microparticles (PMPs) are produced from platelets during activation, storage, and apoptosis. PMP can transfer some adhesion molecules such as CXCR4 to CXCR4-negative cells. In this study, the ability of PMPs to deliver CXCR4 molecule to CXCR4-null targets (Daudi, K562 and U937 cell line) was evaluated and the different concentrations of PMPs were examined to transfer CXCR4.&lt;br&gt;
&lt;strong&gt;&amp;nbsp;&amp;nbsp; Methods:&lt;/strong&gt; In this experimental study, PMPs were prepared using serial centrifugations. After confirmation of PMP with flow cytometry, PMP concentration was evaluated using the Bradford method. CXCR4-negative cell lines (1&amp;times;105 cells/ml) were cultured in RPMI1640 with 10% FBS and 1% antibiotic. PMPs in 7 different concentrations were added to cell culture plates and incubated for 1 hour at 37&amp;ordm;c and 5% CO2. The presence of CXCR4 on cells was analyzed by flowcytometry.&lt;br&gt;
&amp;nbsp;&amp;nbsp; &lt;strong&gt;Results:&lt;/strong&gt; In this study, characterization of PMPs and cell lines were done by flow cytometry. Then, the PMPs&amp;rsquo; ability to transfer CXCR4 to null cells (Daudi, K562 and U937 cell lines) was evaluated in 7 concentrations (10, 20, 50,125, 250, 500, 1000 &amp;mu;g/mL); incubation lasted for 1 hour. The best result of transferring CXCR4 by PMP was done in the concentration of 250&amp;micro;g/mL.&lt;br&gt;
&amp;nbsp;&amp;nbsp; &lt;strong&gt;Conclusion: &lt;/strong&gt;PMPs in different concentrations can transfer CXCR4 to target cells. Also, the increase of PMPs concentration up to 250&amp;micro;g/mL can increase the CXCR4 presence on null cells.&lt;br&gt;
&amp;nbsp;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>CXCR4, Microparticles, Platelet</keyword>
	<start_page>336</start_page>
	<end_page>341</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3101-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Tahereh</first_name>
	<middle_name></middle_name>
	<last_name>Manoochehrabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>manoochehrabadit68@gmail.com</email>
	<code>200319475328460062642</code>
	<orcid>200319475328460062642</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zohreh</first_name>
	<middle_name></middle_name>
	<last_name>Sharifi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.sharifi@ibto.ir</email>
	<code>200319475328460062643</code>
	<orcid>200319475328460062643</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Yari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>f.yari@ibto.ir</email>
	<code>200319475328460062644</code>
	<orcid>200319475328460062644</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
